# APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer

> **NCT06709326** · NA · RECRUITING · sponsor: **Umeå University** · enrollment: 130 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DIAGNOSTIC_TEST:** Apheresis
- **OTHER:** Androgen deprivation therapy
- **DIAGNOSTIC_TEST:** Anti androgen therapy

## Key facts

- **NCT ID:** NCT06709326
- **Lead sponsor:** Umeå University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2020-09-29
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 130 (ESTIMATED)
- **Last updated:** 2024-11-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06709326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06709326, "APACA-Apheresis/acoustophoresis and Molecular Characterization of Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06709326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*